Role of Lymphovascular Invasion in Oral Cavity Squamous Cell Carcinoma Regional Metastasis and Prognosis.

IF 1.3 4区 医学 Q3 OTORHINOLARYNGOLOGY
Abigail E Moore, Sameer A Alvi, Osama Tarabichi, Vivian L Zhu, Marisa R Buchakjian
{"title":"Role of Lymphovascular Invasion in Oral Cavity Squamous Cell Carcinoma Regional Metastasis and Prognosis.","authors":"Abigail E Moore, Sameer A Alvi, Osama Tarabichi, Vivian L Zhu, Marisa R Buchakjian","doi":"10.1177/00034894231211116","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The overall 5-year survival for oral squamous cell carcinoma (OSCC) has not changed in the last 20 years despite advances in treatment. Lymphovascular invasion (LVI) has been shown to be a negative prognostic factor in other cancers, however its role in the prognosis of OSCC remains unclear. This study aims to determine if LVI is a predictor of cervical lymph node metastasis and/or recurrence in OSCC.</p><p><strong>Methods: </strong>We conducted a retrospective cohort review of patients from our institutional cancer registry who were treated for OSCC between 2004 and 2018. Patient demographics, surgical pathology results, and clinical outcome data were collected. A multivariable logistic regression analysis was performed to determine if LVI was an independent predictor of cervical lymph node metastasis and/or recurrence.</p><p><strong>Results: </strong>442 patients were included, 32.8% were female and median age at time of diagnosis was 61.2 years. LVI was present in 32.8% of patients. When controlled for age, sex, t-classification, perineural invasion, depth of invasion (DOI), and margin status, LVI was a significant predictor of the presence of cervical node metastasis (OR: 3.42, CI: 2.17-5.39, <i>P</i> < .001). There was no significant association found between LVI and local recurrence (OR: 1.03, CI: 0.57-1.84, <i>P</i> = .92), regional recurrence (OR: 1.10, CI: 0.57-2.11, <i>P</i> = .78), or distant recurrence (OR: 1.59, CI: 0.87-2.94, <i>P</i> = .13).</p><p><strong>Conclusion: </strong>The results of this study suggest that LVI is a significant predictor of the presence of cervical lymph node metastasis at presentation independent of other known prognostic factors. LVI, however, was not found to be a significant independent predictor of locoregional or distant recurrence.<b>Level of Evidence:</b> Level III.</p>","PeriodicalId":50975,"journal":{"name":"Annals of Otology Rhinology and Laryngology","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Otology Rhinology and Laryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00034894231211116","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/11/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The overall 5-year survival for oral squamous cell carcinoma (OSCC) has not changed in the last 20 years despite advances in treatment. Lymphovascular invasion (LVI) has been shown to be a negative prognostic factor in other cancers, however its role in the prognosis of OSCC remains unclear. This study aims to determine if LVI is a predictor of cervical lymph node metastasis and/or recurrence in OSCC.

Methods: We conducted a retrospective cohort review of patients from our institutional cancer registry who were treated for OSCC between 2004 and 2018. Patient demographics, surgical pathology results, and clinical outcome data were collected. A multivariable logistic regression analysis was performed to determine if LVI was an independent predictor of cervical lymph node metastasis and/or recurrence.

Results: 442 patients were included, 32.8% were female and median age at time of diagnosis was 61.2 years. LVI was present in 32.8% of patients. When controlled for age, sex, t-classification, perineural invasion, depth of invasion (DOI), and margin status, LVI was a significant predictor of the presence of cervical node metastasis (OR: 3.42, CI: 2.17-5.39, P < .001). There was no significant association found between LVI and local recurrence (OR: 1.03, CI: 0.57-1.84, P = .92), regional recurrence (OR: 1.10, CI: 0.57-2.11, P = .78), or distant recurrence (OR: 1.59, CI: 0.87-2.94, P = .13).

Conclusion: The results of this study suggest that LVI is a significant predictor of the presence of cervical lymph node metastasis at presentation independent of other known prognostic factors. LVI, however, was not found to be a significant independent predictor of locoregional or distant recurrence.Level of Evidence: Level III.

淋巴血管侵袭在口腔鳞状细胞癌区域转移和预后中的作用。
目的:口腔鳞状细胞癌(OSCC)的5年生存率在过去20年中没有变化 尽管治疗取得了进展,但仍持续了数年。淋巴血管侵犯(LVI)已被证明是其他癌症的负面预后因素,但其在OSCC预后中的作用尚不清楚。本研究旨在确定LVI是否是OSCC颈淋巴结转移和/或复发的预测因素。方法:我们对2004年至2018年间接受OSCC治疗的癌症机构注册患者进行了回顾性队列回顾。收集患者人口统计学、手术病理学结果和临床结果数据。进行多变量逻辑回归分析,以确定LVI是否是颈淋巴结转移和/或复发的独立预测因素。结果:包括442名患者,32.8%为女性,诊断时的中位年龄为61.2岁 年。32.8%的患者存在LVI。当控制年龄、性别、t分类、神经侵袭、侵袭深度(DOI)和边缘状态时,LVI是颈淋巴结转移存在的显著预测因素(OR:3.42,CI:2.17-5.39,P P = .92),区域复发(OR:1.10,CI:0.57-2.11,P = .78),或远处复发(or:1.59,CI:0.87-2.94,P = .13) 结论:本研究的结果表明,LVI是宫颈淋巴结转移的一个重要预测因素,与其他已知的预后因素无关。然而,LVI并不是局部或远处复发的重要独立预测因素。证据级别:三级。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.10
自引率
7.10%
发文量
171
审稿时长
4-8 weeks
期刊介绍: The Annals of Otology, Rhinology & Laryngology publishes original manuscripts of clinical and research importance in otolaryngology–head and neck medicine and surgery, otology, neurotology, bronchoesophagology, laryngology, rhinology, head and neck oncology and surgery, plastic and reconstructive surgery, pediatric otolaryngology, audiology, and speech pathology. In-depth studies (supplements), papers of historical interest, and reviews of computer software and applications in otolaryngology are also published, as well as imaging, pathology, and clinicopathology studies, book reviews, and letters to the editor. AOR is the official journal of the American Broncho-Esophagological Association.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信